FindMyKOL
Clinical trialNCT01529112CompletedPhase 2Interventional

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

SponsorEisai Inc.Enrollment135Non-Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the overall survival of patients receiving E7080 + Best Supportive Care (BSC) with those receiving placebo + Best Supportive Care.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Olv Ziekenhuis

    Aalst, Belgium

  • Grand Hopital de Charleroi

    Charleroi, Belgium

  • Az Sint-Maarten

    Duffel, Belgium

  • Uz Antwerpen

    Edegem, Belgium

  • Uz Leuven

    Leuven, Belgium

  • C. H. R. de la Citadelle

    Liège, Belgium

  • Domaine Universitaire Du Sart-Tilman

    Liège, Belgium

Czechia
  • Institut Onkologie A Rehabilitace Na Plesi

    Nová Ves pod Pleší, Czechia

  • Avicennus, S.R.O.

    Nymburk, Czechia

  • Fakultni Nemocnice Na Bulovce

    Prague, Czechia

  • Oblastni Nemocnice Pribram, A.S.

    Příbram, Czechia

Hungary
  • Orszagos Koranyi Tbc Es Pulmonologiai Intezet

    Budapest, Hungary

  • Semmelweis Egyetem Aok

    Budapest, Hungary

  • Matrai Gyogyintezet

    Mátraháza, Hungary

  • Fejer Megyei Szent Gyorgy Korhaz

    Székesfehérvár, Hungary

  • Komarom-Esztergom Megyei Onkorm. Szent Borbala Korhaza

    Tatabánya, Hungary

  • Tudogyogyintezet Torokbalint

    Törökbálint, Hungary

  • Zala Megyei Korhaz

    Zalaegerszeg, Hungary

Italy
  • Azienda Ospedaliera G. Rummo

    Benevento, Italy

  • Azienda Ospedaliero Universitaria San Martino

    Genova, Italy

  • Azienda Ospedaliera San Gerardo

    Milan, Italy

  • Istituto Clinico Humanitas

    Milan, Italy

  • Azienda Ospedaliera Universitaria Di Parma

    Parma, Italy

  • Fondazione Salvatore Maugeri Irccs

    Pavia, Italy

  • Azienda Ospedaliera Di Perugia Ospedale S. Maria Della Misericordia

    Perugia, Italy

  • Azienda Ospedaliera San Camillo Forlanini

    Roma, Italy

  • Ospedale Mater Salutis

    Verona, Italy

South Korea
  • Chungbuk National University Hospital

    Chungcheongbuk-do, South Korea

  • Chonnam National University Hwasun Hospital

    Hwasun-gun, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

  • the Catholic University of Korea Yeouido St. Mary'S Hospital

    Seoul, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

United Kingdom
  • the Christie Nhs Foundation Trust

    Manchester, Greater Manchester, United Kingdom

  • Southampton General Hospital

    Southampton, Hampshire, United Kingdom

  • North Staffs Royal Infirmary

    Stoke-on-Trent, Staffordshire, United Kingdom

  • Beatson West of Scotland Cancer Centre

    Glasgow, Strathclyde, United Kingdom

  • New Cross Hospital

    Wolverhampton, West Midlands, United Kingdom

United States
  • Donald W. Hill, M.D., F.A.C.P.

    Casa Grande, Arizona, United States

10 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BSCLenvatinib →Lenvatinib matched placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2011
Primary completion
21 Jan 2014
Completion
27 Jun 2015
Last update posted
26 Sept 2017
Registered enrollment
135
Registry id
NCT01529112

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.